Has tamoxifen had its day?
Tamoxifen is probably the most important drug in the history of the management of breast cancer and its development is a tribute to cross talk between laboratory scientists and clinical investigators. Its use as adjuvant therapy has led to a decrease of 20–30% in age-adjusted cause-specific mortalit...
Kaydedildi:
| Yayımlandı: | Breast Cancer Res |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2002
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137937/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12473165/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr536 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|